Amyloid related cerebral microbleed and plasma Aβ40 are associated with cognitive decline in Parkinson’s disease
Abstract Cerebral microbleeds (MBs) have been found in patients with cognitive decline. We aimed to examine whether MBs are associated with motor or cognitive decline in patients with Parkinson’s disease (PD). We enrolled 135 PD patients and 34 healthy controls. All participants underwent brain MRI...
Guardado en:
Autores principales: | Hsin-Hsi Tsai, Li-Kai Tsai, Yen-Ling Lo, Chin-Hsien Lin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/08340ee754b14fd19a0cc03c0b7cbbcf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Automated detection of cerebral microbleeds on T2*-weighted MRI
por: Anthony G. Chesebro, et al.
Publicado: (2021) -
Imaging Markers of Subcortical Vascular Dementia in Patients With Multiple-Lobar Cerebral Microbleeds
por: Chia-Yen Lin, et al.
Publicado: (2021) -
The Prevalence and Risk Factors of Cerebral Microbleeds: A Community-Based Study in China
por: Luo Q, et al.
Publicado: (2021) -
Plasma Glutathione Levels Decreased with Cognitive Decline among People with Mild Cognitive Impairment (MCI): A Two-Year Prospective Study
por: Chieh-Hsin Lin, et al.
Publicado: (2021) -
TOMM40 ‘523’ poly-T repeat length is a determinant of longitudinal cognitive decline in Parkinson’s disease
por: Megan C. Bakeberg, et al.
Publicado: (2021)